Cargando…
Modulation of Endothelial Injury Biomarkers by Traditional Chinese Medicine LC in Systemic Lupus Erythematosus Patients Receiving Standard Treatments
LC is an herbal remedy effectively reduced therapeutic dosage of glucocorticoid for systemic lupus erythematosus (SLE) patients in clinical trial (ISRCTN81818883). This translational research examined the impact of LC on biomarkers of endothelial injury in the enrolled subjects. Fifty seven patients...
Autores principales: | Chang, Hen-Hong, Luo, Shue-Fen, Hsue, Yin-Tzu, Chang, Ching-Mao, Lee, Tzung-Yan, Huang, Yu-Chuen, Hsu, Ming-Ling, Chen, Yu-Jen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742818/ https://www.ncbi.nlm.nih.gov/pubmed/26847148 http://dx.doi.org/10.1038/srep19622 |
Ejemplares similares
-
Torus Mandibularis in Patients Receiving Hemodialysis
por: Chang, Pei-Ching, et al.
Publicado: (2021) -
Herbal Formula SS-1 Increases Tear Secretion for Sjögren’s Syndrome
por: Chang, Ching-Mao, et al.
Publicado: (2021) -
Leukocyte Mitochondrial DNA Alteration in Systemic Lupus Erythematosus and Its Relevance to the Susceptibility to Lupus Nephritis
por: Lee, Hui-Ting, et al.
Publicado: (2012) -
Molecular and Cellular Bases of Immunosenescence, Inflammation, and Cardiovascular Complications Mimicking “Inflammaging” in Patients with Systemic Lupus Erythematosus
por: Tsai, Chang-Youh, et al.
Publicado: (2019) -
Cardiovascular Disease in Systemic Lupus Erythematosus: The Role of Traditional and Lupus Related Risk Factors
por: Zeller, Carlos Borelli, et al.
Publicado: (2008)